Results 201 to 210 of about 387,637 (267)

Alternative models of consent in out-of-hospital transfusion trials: a CAN-PATT position statement supporting exception from prospective consent with opt-out notification. [PDF]

open access: yesScand J Trauma Resusc Emerg Med
Peddle M   +17 more
europepmc   +1 more source

Application of Cell‐Free DNA Barcode‐Enabled Single‐Molecule Test for Non‐Invasive Prenatal Testing of α‐Thalassemia and β‐Thalassemia

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
We evaluated the cfBEST assay for non‐invasive prenatal testing of α‐ and β‐thalassemia in 72 families. The assay correctly identified 88 of 93 fetal alleles, achieving an overall accuracy of 94.6%, a sensitivity of 94%, and a specificity of 95.35%, with 100% concordance with postnatal follow‐up.
Qin Liu   +7 more
wiley   +1 more source

Molecular and serologic analysis of linked blood donor and recipient samples to rule out transfusion-transmitted parvovirus B19 infection. [PDF]

open access: yesFront Public Health
Miller MJ   +8 more
europepmc   +1 more source

Measurement of Plasma Free Hemoglobin Using the Hemolysis Index of the Mindray BS‐800

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
The Mindray BS‐800 Hemolysis Index provides accurate and reliable measurement of plasma free hemoglobin. Offering an alternative to the Harboe reference method, this technique improves safety and turnaround time. It has strong potential to serve as a practical laboratory marker for accurately differentiating intravascular hemolysis from other causes of
Punchisa Viruttanachai   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy